NYSE:LCI Lannett (LCI) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free LCI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.65▼$2.5152-Week Range N/AVolume280,600 shsAverage Volume92,067 shsMarket Capitalization$7.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. About Lannett Stock (NYSE:LCI)Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.Read More Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. LCI Stock News HeadlinesSeptember 20, 2023 | wsj.comLucky Core Industries Ltd.September 15, 2023 | thestreet.comLannett (LCI) Stock Sinks on Lowered Guidance, Canaccord DowngradeMay 1, 2023 | finance.yahoo.comLannett Company, Inc. Enters Into Restructuring Support AgreementApril 20, 2023 | finance.yahoo.comNYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSApril 4, 2023 | finance.yahoo.comLANNETT SHARES UPDATEFebruary 26, 2023 | thestreet.comWhy Lannett (LCI) Stock Is Down TodayFebruary 7, 2023 | finance.yahoo.comRecent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past yearFebruary 2, 2023 | finance.yahoo.comLannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call TranscriptFebruary 1, 2023 | finance.yahoo.comLANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCEFebruary 1, 2023 | finance.yahoo.comLannett (LCI) Reports Q2 Loss, Tops Revenue EstimatesJanuary 25, 2023 | finance.yahoo.comLANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITJanuary 25, 2023 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1January 4, 2023 | finance.yahoo.comLANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSNovember 9, 2022 | finance.yahoo.comLannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsNovember 7, 2022 | finance.yahoo.comLANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMNovember 2, 2022 | finance.yahoo.comLANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCEOctober 26, 2022 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2October 21, 2022 | finance.yahoo.comLANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTOctober 19, 2022 | prnewswire.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS - PR NewswireOctober 19, 2022 | finance.yahoo.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSOctober 15, 2022 | seekingalpha.comLCI Lannett Company, Inc.October 5, 2022 | finance.yahoo.comLannett Company, Inc. (LCI)September 28, 2022 | law360.comEx-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case - Law360September 26, 2022 | forbes.comProbability Of Default Is Rising For High Yield Bonds And Leveraged Loans - ForbesSeptember 19, 2022 | bloomberg.comAdderall Shortages in US Spread to Two More Drug Suppliers - BloombergSee More Headlines Company Calendar Last Earnings11/03/2021Today5/19/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNYSE:LCI CUSIP51601210 CIK57725 Webwww.lannett.com Phone(215) 333-9000Fax215-333-9004Employees810Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($18.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-231,620,000.00 Net Margins-62.40% Pretax Margin-62.67% Return on EquityN/A Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio1.39 Sales & Book Value Annual Sales$340.58 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($23.34) per share Price / BookN/AMiscellaneous Outstanding Shares10,770,000Free Float9,354,000Market Cap$7.38 million OptionableOptionable Beta0.95 Key ExecutivesTimothy C. CrewChief Executive Officer & DirectorJohn KozlowskiChief Financial Officer & Vice President-FinanceRobert EhlingerChief Information Officer & Vice PresidentMaureen M. CavanaughChief Commercial Operations Officer & Senior VPJohn M. AbtChief Quality Operations Officer & Vice PresidentKey CompetitorsCumberland PharmaceuticalsNASDAQ:CPIXeFFECTOR TherapeuticsNASDAQ:EFTROragenicsNYSE:OGENVirios TherapeuticsNASDAQ:VIRICan-Fite BioPharmaNYSE:CANFView All Competitors LCI Stock Analysis - Frequently Asked Questions How were Lannett's earnings last quarter? Lannett Company, Inc. (NYSE:LCI) released its quarterly earnings data on Wednesday, November, 3rd. The company reported ($1.08) earnings per share for the quarter, missing analysts' consensus estimates of ($1.00) by $0.08. The business earned $101.53 million during the quarter, compared to the consensus estimate of $98.62 million. During the same quarter in the prior year, the business earned $0.24 earnings per share. When did Lannett's stock split? Shares of Lannett reverse split before market open on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What is Timothy Crew's approval rating as Lannett's CEO? 9 employees have rated Lannett Chief Executive Officer Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among the company's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Lannett own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA). This page (NYSE:LCI) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding Lannett Company, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.